ABSTRACT
BACKGROUND: To ensure health related quality of life (HRQOL) during the survival of patients with prostate cancer (PCa) is a priority. The development of specific HRQOL questionnaires aids to assess the disease impact, its treatment and the patient's perception (concerns, expectations and interests) that might go unnoticed. OBJECTIVES: To develop and validate the first Spanish HRQL questionnaire specific for patients with PCa. MATERIALS AND METHODS: The questionnaire CAVIPRES had 3 phases of development: 1.-generation of items (literature research, expert meeting and 2 focus groups with patients), 2.- reduction of items (self-administered survey with a preliminary version and clinimetric and psychometric analyses), 3: validation of the questionnaire (observational study with 2 visits where patients completed the CAVIPRES, SF-36 and UCLA-PCI tests and analysis of psychometric properties in terms of validity, reliability and sensitivity to change). RESULTS: A preliminary list of 75 potential items was obtained in phase 1.412 patients were recruited and answered this preliminary version in phase 2. 35 items were deleted. 436 patients responded to the definitive-30-items obtained version (CAVIPRES-30) in Phase 3. CAVIPRES-30 showed feasibility (items lost <4%, ceiling effect: 0% floor effect: 0% in the overall score), high reliability in terms of internal consistency (alpha = 0.77) and re-test reliability (ICC = 0.92). There was a good correlation between tests CAVIPRES and SGF-36 and UCLA-PCI for similar domains CONCLUSION: The questionnaire CAVIPRES-30 is a feasible, reliable and sensitive to change, useful in clinical research for prostate cancer.
Subject(s)
Prostatic Neoplasms/psychology , Quality of Life , Surveys and Questionnaires , Humans , Language , MaleABSTRACT
Introducción: Asegurar calidad de vida relacionada con la salud (CVRS) durante la supervivencia del paciente con cáncer de próstata (CaP) es primordial. El desarrollo de cuestionarios específicos de CVRS facilita evaluar el impacto de la enfermedad, de su tratamiento y aspectos de percepción del paciente (preocupaciones, expectativas e intereses) que podrían pasar desapercibidos. Objetivos: Desarrollar y validar el primer cuestionario español de CVRS específico para pacientes con CaP. Materiales y métodos: El cuestionario CAVIPRES tuvo 3 fases de desarrollo: 1-generación de ítems (investigación documental, sesión de expertos y 2 grupos de discusión con pacientes), 2-reducción de ítems (encuesta auto administrada con el precuestionario y análisis clinimétrico y psicométrico), 3: validación del cuestionario (estudio observacional con 2 entrevistas al paciente que completaba los tests CAVIPRES, SF-36 y UCLA-PCI y análisis de propiedades psicométricas en términos de validez, fiabilidad y sensibilidad al cambio).Resultados: La fase 1 generó un precuestionario de 75 potenciales ítems. En la fase 2, 412 pacientes respondieron a la versión preliminar y se excluyeron 35 ítems. En la fase 3, 436 pacientes respondieron a la versión prevalidada. Se obtuvo un cuestionario de 30 ítems para investigación clínica (CAVIPRES-30). El CAVIPRES-30 mostró viabilidad (ítems perdidos <4%), factibilidad (efecto techo: 0% y efecto suelo: 0% en la puntuación global), alta fiabilidad en cuanto a consistencia interna (alfa=0,77) y a fiabilidad re-test (CCI=0,92). Hubo una buena correlación entre CAVIPRES y los tests SGF-36 y UCLA-PCI para dimensiones semejantes. Conclusión: El cuestionario CAVIPRES-30 es un instrumento factible, fiable y sensible al cambio, útil en la investigación clínica del cáncer de próstata (AU)
Background: To ensure health related quality of life (HRQOL) during the survival of patients with prostate cancer (PCa) is apriority. The development of specific HRQOL questionnaires aids to assess the disease impact, its treatment and the patients perception (concerns, expectations and interests) that might go unnoticed. Objectives: To develop and validate the first Spanish HRQL questionnaire specific for patients with PCa. Materials and methods: The questionnaire CAVIPRES had 3 phases of development:1.-generation of items (literature research, expert meeting and 2 focus groups with patients), 2.- reduction of items (self-administered survey with a preliminary version and clinimetric and psychometric analyses), 3: validation of the questionnaire (observational study with 2 visits where patients completed the CAVIPRES, SF-36 and UCLA-PCI tests and analysis of psychometric properties in terms of validity, reliability and sensitivity to change).Results: A preliminary list of 75 potential items was obtained in phase 1.412 patients were recruited and answered this preliminary version in phase 2. 35 items were deleted. 436 patients responded to the definitive-30-ítems obtained version (CAVIPRES-30) in Phase 3. CAVIPRES-30 showed feasibility (items lost <4%, ceiling effect: 0% floor effect: 0% in the overall score),high reliability in terms of internal consistency (alpha = 0.77) and re-test reliability (ICC = 0.92). There was a good correlation between tests CAVIPRES and SGF-36 and UCLA-PCI for similar domains. Conclusion: The questionnaire CAVIPRES-30 is a feasible, reliable and sensitive to change, useful in clinical research for prostate cancer (AU)
Subject(s)
Humans , Male , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/therapy , Quality of Life , Quality of Life/psychology , Patients , Perception , Surveys and Questionnaires , Observational Studies as Topic , Feasibility Studies , Validation Studies as TopicABSTRACT
INTRODUCTION: Radical cystectomy in elderly is a controversial issue that increases importance overtime because average life span is growing. OBJECTIVE: The purpose of our work was to analize the differences about perioperative and later outcomes between ages of patients with muscle-invasive bladder neoplasm treated with radical cystectomy. MATERIAL AND METHODS: We retrospectively reviewed the records of patients who underwent radical cystectomy for muscle-invasive bladder cancer. Two age groups were compared: < 70-years-old at time of cystectomy (n = 55) and > or = 70 years (n = 57). RESULTS: There was no difference between both age groups about: time of surgery, intraoperative complications (< 70 = 21,8%, > or = 70 = 31,6%), postoperative mortality (< 70 = 3,6%, > or = 70 = 8,8%), minor (< 70 = 18,2%, > or = 70 = 26,3%) and major medical postoperative complications (< 70 = 7,3%, > or = 70 = 8,8%), late outcomes as cancer-specific morby-mortality and actuarial overall survival stratified by patient age. The rate of major postoperative complications (< 70 = 23,6%, > or = 70 = 43,9%) as well as the mean length of hospital stay (< 70 = 10,2, > or = 70 = 15,2 days) differed significantly between the two age groups. Age and cardiovascular risk factors were independient predictive factors of mayor postoperative complications. CONCLUSIONS: Radical cystectomy could be performed in carefully selected elderly patients.
Subject(s)
Cystectomy , Urinary Bladder Neoplasms/surgery , Adult , Age Factors , Aged , Aged, 80 and over , Cystectomy/adverse effects , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness , Postoperative Complications/epidemiology , Retrospective Studies , Urinary Bladder Neoplasms/pathologyABSTRACT
Introducción: Realizar una cistectomía radical en ancianos con cáncer vesical infiltrante es un tema controvertido. Objetivo: El objetivo de nuestro trabajo ha sido determinar si existen diferencias significativas en cuanto a la morbimortalidad perioperatoria, complicaciones tardías, tiempo libre de enfermedad y supervivencia cáncer-específica en un grupo de pacientes ancianos con cáncer vesical infiltrante tratados mediante cistectomía radical, comparado al resto de pacientes de menor edad y analizar qué variables pudieron predecir la morbi-mortalidad perioperatoria. Material y métodos: Estudio retrospectivo de pacientes con cáncer vesical infiltrante tratados mediante cistectomía radical y derivación ileal. Se compararon 2 grupos: <70 años en el momento de la realización de la cistectomía (n=55) y≥70 años (n=57). Resultados: No hubo diferencias entre ambos grupos con respecto a: tiempo quirúrgico, complicaciones intraoperatorias (<70=21,8%, ≥70=31,6%), mortalidad postoperatoria (<70=3,6%, ≥70=8,8%), complicaciones postoperatorias menores(<70=18,2%, ≥70=26,3%) y médicas (<70=7,3%, ≥70=8,8%), eventos tardíos, periodo libre de enfermedad y supervivencia cáncer-específica. El porcentaje de complicaciones mayores (<70=23,6%, ≥70=43,9%) y la estancia hospitalaria (<70=10,2,≥70=15,2 días) difieren significativamente entre ambos grupos. La edad y los factores de riesgo cardiacos predicen de manera independiente la aparición de complicaciones postoperatorias mayores. Conclusiones: La cistectomía radical puede ser realizada en pacientes ancianos seleccionados adecuadamente (AU)
Introduction: Radical cystectomy in elderly is a controversial issue that increases importance overtime because average life span is growing. Objetive: The porpouse of our work was to analize the differences about perioperative and later outcomes between ages of patients with muscle-invasive bladder neoplasm treated with radical cystectomy. Material and methods: We retrospectively reviewed the records of patients who underwent radical cystectomy for muscle-invasive bladder cancer. Two age groups were compared: <70 years old at time of cystectomy (n=55) and ≥70 years(n=57).Results: There was no difference between both age groups about: time of surgery, intraoperative complications (<70=21,8%,≥70=31,6%), postoperative mortality (<70=3,6%, ≥70=8,8%), minor (<70=18,2%, ≥70=26,3%) and major medical postoperative complications (<70=7,3%, ≥70=8,8%), late outcomes as cancer-specific morby-mortality and actuarial overall survival stratified by patient age. The rate of major postoperative complications (<70=23,6%, ≥70=43,9%) as well as the mean length of hospital stay (<70=10,2, ≥70=15,2 days) differed significantly between the two age groups. Age and cardiovascular risk factors were independient predictive factors of mayor postoperative complications. Conclusions: Radical cystectomy could be performed in carefully selected elderly patients (AU)